Health In Tech, Inc. filings document material-event disclosures for a Nevada operating company with Class A common stock listed on the Nasdaq Capital Market under HIT. Recent Form 8-K reports cover results of operations and financial condition, Regulation FD materials, investor presentations and conference-call transcripts.
The filing record also addresses capital-structure matters, including a private investment in public equity financing, and governance disclosures involving executive officer departures, compensatory arrangements and related consulting agreements. The company identifies as an emerging growth company in its Exchange Act reports.
Health In Tech, Inc. director Timothy Hayes reported selling 12,000 shares of Class A Common Stock on September 14, 2026. The weighted average sale price was $0.893 per share, with individual trades between $0.8694 and $0.943. Following this transaction, Hayes holds 108,780 shares directly. No Rule 10b5-1 trading plan is reported.
Health In Tech, Inc. (HIT) filed a notice that director Timothy Hayes may sell up to 12,000 shares of the company’s common stock, to be sold through Apex Clearing on the Nasdaq Stock Market, with an aggregate market value of $10,776.00 as of September 14, 2026. The shares relate to a Restricted Stock Award that vested on June 23, 2025. The notice also reports prior sales by Hayes over the past three months totaling 5,730 shares for $5,352.81 on September 9, 2026 and 12,000 shares for $11,010.59 on September 11, 2026.
Health In Tech, Inc. (HIT) director Timothy Hayes filed a Rule 144 notice indicating an intention to sell shares of the company’s common stock. Hayes reports beneficial ownership of 17,730 shares, with an aggregate market value of $16,363.40, held at Apex Clearing.
The notice lists planned sales tied to restricted stock award vesting events: 12,000 shares vesting on October 3, 2025 and 5,730 shares vesting on January 8, 2026, with both blocks indicated for potential sale on October 8, 2025.
Health In Tech, Inc. (HIT) disclosed that Chief Growth Officer Hasan Zain Syed sold 11,667 shares of Class A Common Stock on September 11, 2026 at a weighted average price of $0.92 per share in an open-market or private transaction. After this sale, he held 188,544 shares directly. The sale was carried out under a Rule 10b5-1 trading plan adopted on June 11, 2026, and the reported price reflects a weighted average of multiple trades between $0.9103 and $0.9541 per share.
Health In Tech, Inc. (HIT) reported that director Timothy Hayes sold Class A Common Stock in two recent transactions. On September 11, 2026 he sold 12,000 shares at $0.91 per share, and on September 9, 2026 he sold 5,730 shares at $0.93 per share, for total reported sales of 17,730 shares, all held directly. No Rule 10b5-1 trading plan is reported for these sales, and the filing does not state his remaining shareholdings.
Health In Tech, Inc. (HIT) insider Hasan Zain Syed, identified as Chief Growth Officer, has filed a notice of intent to sell up to 18,334 shares of common stock under Rule 144. The planned sales, with an aggregate market value of $17,169.79, may begin on or about September 11, 2026, through APEX CLEARING on the Nasdaq Stock Market and will be executed pursuant to a Rule 10b5-1 trading plan.
Health In Tech, Inc. (HIT) filed a shelf registration to permit YA II PN, LTD (Yorkville) to resell up to 29,532,889 shares of its Class A common stock that may be issued under a Standby Equity Purchase Agreement (SEPA) and related Convertible Notes. The registration covers 9,532,889 Conversion Shares issuable upon note conversions and 20,000,000 Advance Shares issuable through equity advances. Health In Tech will not receive proceeds from Yorkville’s resale of these shares, but may receive up to $14.25 million from Convertible Notes and up to $20.0 million from share sales to Yorkville under the SEPA, with initial proceeds used to repay the notes. As of September 2, 2026, shares outstanding were 53,702,649, and Nasdaq rules impose a 13,100,378‑share Exchange Cap and a 4.99% Beneficial Ownership Limitation, so additional issuances would require stockholder approval. The company describes significant potential dilution to existing holders and expects longer‑term SEPA proceeds, once available beyond note repayment, to support sales expansion, technology and product development, and working capital.
Health In Tech, Inc. director and Chief Financial Officer Qian LinLin reported a disposition of Class A Common Stock related to tax withholding. On 2026-08-13, 28,183 shares of Class A Common Stock were surrendered to the company at $1.06 per share to satisfy tax withholding and remittance obligations arising from the vesting of previously granted restricted shares. After this transaction, Qian LinLin directly holds 8,998,392 Class A Common Stock, consisting of 938,743 restricted shares and 8,059,649 unrestricted shares. The reported total excludes 2,700,000 shares of Class B Common Stock and 711,510 options to purchase Class A Common Stock.
Health In Tech, Inc. director and Chief Executive Officer Tim Donald Johnson reported a code F transaction involving restricted Class A Common Stock. On 2026-08-13, 46,327 shares of Class A Common Stock were surrendered to the company at $1.06 per share to satisfy tax withholding and remittance obligations arising from the vesting of restricted shares.
After this withholding transaction, Johnson directly holds 23,334,365 Class A shares, consisting of 842,491 restricted and 22,491,874 unrestricted Class A shares. In addition, the disclosure notes that this figure excludes 9,000,000 shares of Class B Common Stock and 734,707 options to purchase Class A Common Stock.
Health In Tech, Inc. officer Hasan Zain Syed reported a disposition of 4,007 shares of Class A Common Stock on 2026-08-13 at $1.06 per share. The shares were surrendered to cover tax withholding related to vesting of previously granted restricted stock. After this tax-withholding disposition, Syed directly holds 200,211 shares, including 179,326 restricted and 20,885 unrestricted shares of Class A Common Stock.